BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21531726)

  • 41. p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex.
    Zhou Z; Cao JX; Li SY; An GS; Ni JH; Jia HT
    Exp Cell Res; 2013 Dec; 319(20):3104-15. PubMed ID: 24076372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two functionally divergent p53-responsive elements in the rat bradykinin B2 receptor promoter.
    Marks J; Saifudeen Z; Dipp S; El-Dahr SS
    J Biol Chem; 2003 Sep; 278(36):34158-66. PubMed ID: 12791684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification and characterization of the cytoplasmic protein TRAF4 as a p53-regulated proapoptotic gene.
    Sax JK; El-Deiry WS
    J Biol Chem; 2003 Sep; 278(38):36435-44. PubMed ID: 12788948
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
    Shivakumar CV; Das GC
    Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor suppressor p53 can participate in transcriptional induction of the GADD45 promoter in the absence of direct DNA binding.
    Zhan Q; Chen IT; Antinore MJ; Fornace AJ
    Mol Cell Biol; 1998 May; 18(5):2768-78. PubMed ID: 9566896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y.
    Faniello MC; Di Sanzo M; Quaresima B; Baudi F; Di Caro V; Cuda G; Morrone G; Del Sal G; Spinelli G; Venuta S; Costanzo F
    Int J Biochem Cell Biol; 2008; 40(10):2110-9. PubMed ID: 18372207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites.
    Golubovskaya V; Kaur A; Cance W
    Biochim Biophys Acta; 2004 May; 1678(2-3):111-25. PubMed ID: 15157737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of chemokine-induced lymphocyte migration by RGS proteins.
    Moratz C; Harrison K; Kehrl JH
    Methods Enzymol; 2004; 389():15-32. PubMed ID: 15313557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of the small heat shock protein alphaB-crystallin by genotoxic stress is mediated by p53 and p73.
    Evans JR; Bosman JD; Brown-Endres L; Yehiely F; Cryns VL
    Breast Cancer Res Treat; 2010 Jul; 122(1):159-68. PubMed ID: 19777343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The muscle regulatory transcription factor MyoD participates with p53 to directly increase the expression of the pro-apoptotic Bcl2 family member PUMA.
    Harford TJ; Kliment G; Shukla GC; Weyman CM
    Apoptosis; 2017 Dec; 22(12):1532-1542. PubMed ID: 28918507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites.
    Rossi M; Demidov ON; Anderson CW; Appella E; Mazur SJ
    Nucleic Acids Res; 2008 Dec; 36(22):7168-80. PubMed ID: 19015127
    [TBL] [Abstract][Full Text] [Related]  

  • 52. p53-dependent suppression of uridine phosphorylase gene expression through direct promoter interaction.
    Zhang D; Cao D; Russell R; Pizzorno G
    Cancer Res; 2001 Sep; 61(18):6899-905. PubMed ID: 11559567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cloning and characterization of rabbit Rgs4 promoter in gut smooth muscle.
    Li F; Murthy KS; Khalili K; Hu W
    Gene; 2010 Feb; 451(1-2):45-53. PubMed ID: 19945517
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation.
    Saifudeen Z; Dipp S; Fan H; El-Dahr SS
    Am J Physiol Renal Physiol; 2005 May; 288(5):F899-909. PubMed ID: 15632413
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response.
    Wei X; Xu H; Kufe D
    Cancer Cell; 2005 Feb; 7(2):167-78. PubMed ID: 15710329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
    Takimoto R; El-Deiry WS
    Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progesterone up-regulates p27 through an increased binding of the progesterone receptor-A-p53 protein complex onto the non-canonical p53 binding motif in HUVEC.
    Hsu SP; Lin PH; Chou CM; Lee WS
    J Steroid Biochem Mol Biol; 2019 Jan; 185():163-171. PubMed ID: 30145226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Binding sequence-dependent regulation of the human proliferating cell nuclear antigen promoter by p53.
    Shan B; Morris GF
    Exp Cell Res; 2005 Apr; 305(1):10-22. PubMed ID: 15777783
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Negative regulation of Rb expression by the p53 gene product.
    Shiio Y; Yamamoto T; Yamaguchi N
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5206-10. PubMed ID: 1608930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53.
    Morris GF; Bischoff JR; Mathews MB
    Proc Natl Acad Sci U S A; 1996 Jan; 93(2):895-9. PubMed ID: 8570655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.